Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company.pdf2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company
- Press Release.pdfPress Release
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 12 | / | 2026 | ||||||||
| Date of issue: | 2026-03-12 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka, d. d., Novo mesto | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 17 ust. 1 MAR | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on Article 26 of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto publishes 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka d. d., Novo mesto with relavant notes. The report will be published on the Company's website (www.krka.biz) from 12 March 2026 onwards, for a minimum period of 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company.pdf 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company.pdf | 2025 Unaudited consolidated financial statements of the Krka Group and unaudited financial statements of the Krka Company | ||||||||||
| Press Release.pdf Press Release.pdf | Press Release | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2026-03-12 | Jože Colarič | President of the Management Board and CEO | |||
